Key result
Systolic blood pressure of 140-149 mmHg increased the hazard of end-stage renal disease and all-cause death compared to 120-129 mmHg in adults with chronic kidney disease.
Why the study?
The effect of blood pressure on incident cardiovascular events, progression to end-stage renal disease, and mortality needed evaluation among chronic kidney disease patients with and without antihypertensive treatment.
Does maintaining systolic blood pressure at 120-129 mmHg and diastolic blood pressure at 70-79 mmHg improve the composite outcome of ESRD and all-cause death in adults with chronic kidney disease?
Cohort (n=22,278)
Yes
Does maintaining systolic blood pressure at 120-129 mmHg and diastolic blood pressure at 70-79 mmHg improve the composite outcome of ESRD and all-cause death in adults with chronic kidney disease?
In patients with chronic kidney disease, maintaining a blood pressure of 120-129/70-79 mmHg is optimal, as both higher blood pressures and excessive lowering (SBP < 100 mmHg) with antihypertensive medications are associated with increased risks of ESRD and mortality.
Answers are grounded in this paper and cite their sources.
SBP 140-149 mmHg was associated with higher ESRD and mortality risk in CKD; extends observational data but leaves optimal targets open for RCTs.
The effect of blood pressure (BP) on the incident cardiovascular events, progression to end-stage renal disease (ESRD) and mortality were evaluated among chronic kidney disease (CKD) patients with and without antihypertensive treatment. This nationwide study used the Korean National Health Insurance Service-Health Screening Cohort data. The hazards of outcomes were analysed according to the systolic BP (SBP) or diastolic BP (DBP) among adults (aged ≥ 40 years) with CKD and without previous cardiovascular disease or ESRD (n = 22,278). The SBP and DBP were ≥ 130 mmHg and ≥ 80 mmHg in 10,809 (48.52%) and 11,583 (51.99%) participants, respectively. During a median 6.2 years, 1271 cardiovascular events, 201 ESRD incidents, and 1061 deaths were noted. Individuals with SBP ≥ 130 mmHg and DBP ≥ 80 mmHg had higher hazards of hypertension-related adverse outcomes compared to the references (SBP 120-129 mmHg and DBP 70-79 mmHg). SBP < 100 mmHg was associated with hazards of all-cause death, and composite of ESRD and all-cause death during follow-up only among the antihypertensive medication users suggesting that the BP should be < 130/80 mmHg and the SBP should not be < 100 mmHg with antihypertensive agents to prevent the adverse outcome risk of insufficient and excessive antihypertensive treatment in CKD patients.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) conducted a cohort in Chronic kidney disease (n=22,278). Systolic blood pressure 140-149 mmHg vs. Systolic blood pressure 120-129 mmHg was evaluated on Composite of progression to end-stage renal disease and all-cause death (HR 1.443, 95% CI 1.190-1.751, p=<0.0001). Systolic blood pressure of 140-149 mmHg increased the hazard of end-stage renal disease and all-cause death compared to 120-129 mmHg in adults with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: